This is an unofficial archive of PsychonautWiki as of 2025-08-11T15:14:44Z. Content on this page may be outdated, incomplete, or inaccurate. Please refer to the original page for the most up-to-date information.
MDEA: Difference between revisions
>Unity No edit summary |
>Unity No edit summary |
||
| Line 8: | Line 8: | ||
'''MDEA''' (also known as '''3,4-methylenedioxy-N-ethylamphetamine''', '''MDE''' or '''Eve''') is a [[stimulant]] and [[Psychoactive class::entactogen]]ic drug of the [[phenethylamine]] and [[Chemical class::Substituted amphetamines|substituted amphetamine]] classes and a closely related structural analog of [[MDMA]] and [[MDA]]. <ref>PiHKAL|http://isomerdesign.com/PiHKAL/read.php?domain=pk&id=106</ref> | '''MDEA''' (also known as '''3,4-methylenedioxy-N-ethylamphetamine''', '''MDE''' or '''Eve''') is a [[stimulant]] and [[Psychoactive class::entactogen]]ic drug of the [[phenethylamine]] and [[Chemical class::Substituted amphetamines|substituted amphetamine]] classes and a closely related structural analog of [[MDMA]] and [[MDA]]. <ref>PiHKAL|http://isomerdesign.com/PiHKAL/read.php?domain=pk&id=106</ref> | ||
In a 1967 lab notebook entry, Alexander Shulgin briefly mentioned a colleague's report of no effect from the substance with a 100mg dose.<ref>Rediscovering MDMA (ecstasy): the role of the American chemist Alexander T. Shulgin|doi=10.1111/j.1360-0443.2010.02948.x}}</ref> Shulgin later tested the compound at a range of higher doses and characterized the substance in his book [[PiHKAL]].<ref>PiHKAL|http://isomerdesign.com/PiHKAL/read.php?domain=pk&id=106</ref> | In a 1967 lab notebook entry, Alexander Shulgin briefly mentioned a colleague's report of no effect from the substance with a 100mg dose.<ref>Rediscovering MDMA (ecstasy): the role of the American chemist Alexander T. Shulgin|doi=10.1111/j.1360-0443.2010.02948.x}}</ref> Shulgin later tested the compound at a range of higher doses and characterized the substance in his book "[[PiHKAL]]" ("[[Phenethylamine]]s I Have Known and Loved").<ref>PiHKAL|http://isomerdesign.com/PiHKAL/read.php?domain=pk&id=106</ref> | ||
In the United States, MDEA was introduced recreationally in 1985 as a legal substitute to the newly banned MDMA before it was made a Schedule I substance two years later on August 13, 1987 under the Federal Analog Act.<ref>PiHKAL|http://isomerdesign.com/PiHKAL/read.php?domain=pk&id=106</ref> Since then, MDEA is rarely sold on its own and has historically been used as an occasional additive or substitute ingredient in pills of "Ecstasy", with studies conducted in the 1990s having found MDEA present in approximately four percent of ecstasy tablets.<ref> The Neuropsychopharmacology and Toxicology of 3,4-methylenedioxy-N-ethyl-amphetamine (MDEA) | http://onlinelibrary.wiley.com/doi/10.1111/j.1527-3458.2004.tb00007.x/pdf</ref> | In the United States, MDEA was introduced recreationally in 1985 as a legal substitute to the newly banned MDMA before it was made a Schedule I substance two years later on August 13, 1987 under the Federal Analog Act.<ref>PiHKAL|http://isomerdesign.com/PiHKAL/read.php?domain=pk&id=106</ref> Since then, MDEA is rarely sold on its own and has historically been used as an occasional additive or substitute ingredient in pills of "Ecstasy", with studies conducted in the 1990s having found MDEA present in approximately four percent of ecstasy tablets.<ref> The Neuropsychopharmacology and Toxicology of 3,4-methylenedioxy-N-ethyl-amphetamine (MDEA) | http://onlinelibrary.wiley.com/doi/10.1111/j.1527-3458.2004.tb00007.x/pdf</ref> | ||